Dexcom (DXCM) Rises 5.16% for June 23

Equities Staff  |

Today, Dexcom Inc (NASDAQ:DXCM) rose $3.69 to close Thursday at $75.21.

The company opened at $72.55 and shares fluctuated between $75.59 and $71.87 with 2,310,553 shares trading hands.

Dexcom is averaging 4,749,416 shares traded over the last 30 days. They have lost 46.72% YTD.

Dexcom anticipates its next earnings on 2022-07-28.

For technical charts, analysis, and more on Dexcom visit the company profile.

About Dexcom Inc

DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) products. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of patients, caregivers, and clinicians, Dexcom simplifies and improves diabetes management around the world.

To get more information on Dexcom Inc and to follow the company's latest updates, you can visit the company's profile page here: Dexcom Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

The Best Laid Plans of Mice and Men — Part II
Why I’m Buying the 'New' Value Stocks
Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade



Market Movers

Sponsored Financial Content